Sanofi

Research Sanofi (SNW) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• TickerSNW
• ExchangeHM
• CountryFrance
• SectorHealthcare
• IndustryDrug Manufacturers - General
• CurrencyEUR
• Financial periodFY2025
• RevenueEUR 43.63B
• Revenue growth6.2%
• Net incomeEUR 7.85B
• Gross margin77.2%

About Sanofi

Preamble Sanofi and its subsidiaries ("Sanofi", "the Group" or "the Company") are a global leader in healthcare, researching, developing, and commercializing therapeutic solutions centered on patient needs. Sanofi is listed on Euronext Paris (Ticker: SAN) and the Nasdaq (Ticker: SNY). The consolidated annual financial statements as of December 31, 2025, along with the corresponding notes, were approved by Sanofi's Board of Directors on January 28, 2026. C/ Principal Agreements C.1.

Frequently asked questions

What does Sanofi do?

Preamble Sanofi and its subsidiaries ("Sanofi", "the Group" or "the Company") are a global leader in healthcare, researching, developing, and commercializing therapeutic solutions centered on patient needs. Sanofi is listed on Euronext Paris (Ticker: SAN) and the Nasdaq (Ticker: SNY).